表紙
市場調查報告書

抗病毒藥物的全球市場的預測

Antivirals Global Market Report 2020

出版商 The Business Research Company 商品編碼 916208
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
抗病毒藥物的全球市場的預測 Antivirals Global Market Report 2020
出版日期: 2019年11月01日內容資訊: 英文
簡介

本報告提供全球抗病毒藥物市場相關調查分析,市場特徵、規模、成長率,區分,各地區、各國明細,競爭情形,市場佔有率,趨勢、策略相關的系統性資訊。

第1章 摘要整理

第2章 抗病毒藥物市場特徵

第3章 抗病毒藥物市場規模、成長率

  • 市場成果 (金額)
  • 市場預測 (金額)

第4章 抗病毒藥物市場區隔

  • 各治療
  • 各終端用戶
  • 各標的
  • 各類型

第5章 抗病毒藥物市場各地區、各國分析

  • 各地區
  • 各國

第6章 亞太地區的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第7章 中國的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第8章 印度的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第9章 日本的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第10章 澳洲的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第11章 印尼的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第12章 韓國的抗病毒藥物市場

  • 市場概要
  • 各治
  • 各終端用戶

第13章 西歐的抗病毒藥物市場

第14章 英國的抗病毒藥物市場

第15章 德國的抗病毒藥物市場

第16章 法國的抗病毒藥物市場

第17章 東歐的抗病毒藥物市場

第18章 俄羅斯的抗病毒藥物市場

第19章 北美的抗病毒藥物市場

第20章 美國的抗病毒藥物市場

第21章 南美的抗病毒藥物市場

第22章 巴西的抗病毒藥物市場

第23章 中東的抗病毒藥物市場

第24章 非洲的抗病毒藥物市場

第25章 抗病毒藥物市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介

第26章 抗病毒藥物市場主要M&A

第27章 抗病毒藥物市場趨勢與策略

第28章 產品平台分析

第29章 抗病毒藥物市場未來發展預測與可能性分析

第30章 附錄

目錄

Title:
Antivirals Global Market Report 2020 - Including: 1) By Therapeutics: HIV/AIDS Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics, Influenza Therapeutics, Others (Pneumonia) 2) By End User: Hospitals, Clinics, Ambulatory surgical center 3) By Target: DNA polymerase, NS3 Protease, Reverse transcriptase, Others 4) By Drug Type: Generic, Branded Covering: Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc, Roche Holding AG, Gilead Sciences.

Antivirals Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antivirals market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antivirals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antivirals Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

  • Markets Covered: 1) By Therapeutics: HIV/AIDS Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics, Influenza Therapeutics, Others (Pneumonia) 2) By End User: Hospitals, Clinics, Ambulatory surgical center 3) By Target: DNA polymerase, NS3 Protease, Reverse transcriptase, Others 4) By Drug Type: Generic, Branded
  • Companies Mentioned: Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc, Roche Holding AG , Gilead Sciences
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antivirals Market Characteristics

3. Antivirals Market Size And Growth

  • 3.1. Global Antivirals Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Antivirals Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Antivirals Market Segmentation

  • 4.1. Global Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • HIV/AIDS Therapeutics
  • Hepatitis (B & C) Therapeutics
  • Herpes Therapeutics
  • Influenza Therapeutics
  • Others (Pneumonia)
  • 4.2. Global Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory surgical center
  • 4.3. Global Antivirals Market, Segmentation By Target, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • DNA polymerase
  • NS3 Protease
  • Reverse transcriptase
  • Others
  • 4.4. Global Antivirals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Generic
  • Branded

5. Antivirals Market Regional And Country Analysis

  • 5.1. Global Antivirals Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Antivirals Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antivirals Market

  • 6.1. Asia-Pacific Antivirals Market Overview
  • 6.2. Asia-Pacific Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Antivirals Market

  • 7.1. China Antivirals Market Overview
  • 7.2. China Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Antivirals Market

  • 8.1. India Antivirals Market Overview
  • 8.2. India Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Antivirals Market

  • 9.1. Japan Antivirals Market Overview
  • 9.2. Japan Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Antivirals Market

  • 10.1. Australia Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Antivirals Market

  • 11.1. Indonesia Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Antivirals Market

  • 12.1. South Korea Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Antivirals Market

  • 13.1. Western Europe Antivirals Market Overview
  • 13.2. Western Europe Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Antivirals Market

  • 14.1. UK Antivirals Market Overview
  • 14.2. UK Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Antivirals Market

  • 15.1. Germany Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Antivirals Market

  • 16.4. France Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Antivirals Market

  • 17.1. Eastern Europe Antivirals Market Overview
  • 17.2. Eastern Europe Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Antivirals Market

  • 18.1. Russia Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Antivirals Market

  • 19.1. North America Antivirals Market Overview
  • 19.2. North America Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Antivirals Market

  • 20.1. USA Antivirals Market Overview
  • 20.2. USA Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Antivirals Market

  • 21.1. South America Antivirals Market Overview
  • 21.2. South America Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Antivirals Market

  • 22.1. Brazil Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Antivirals Market

  • 23.1. Middle East Antivirals Market Overview
  • 23.2. Middle East Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Antivirals Market

  • 24.1. Africa Antivirals Market Overview
  • 24.2. Africa Antivirals Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Antivirals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Antivirals Market Competitive Landscape And Company Profiles

  • 25.1. Antivirals Market Competitive Landscape
  • 25.2. Antivirals Market Company Profiles
    • 25.2.1. Merck & Co. Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Johnson & Johnson
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. GlaxoSmithKline Plc
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Roche Holding AG
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Gilead Sciences
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antivirals Market

27. Antivirals Market Trends And Strategies

28. Product Pipeline Analysis

29. Antivirals Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top